Label: RANITIDINE tablet

  • NDC Code(s): 55111-131-04, 55111-131-14, 55111-131-30, 55111-131-37, view more
    55111-131-45, 55111-131-60, 55111-131-79, 55111-131-80, 55111-131-81, 55111-131-90
  • Packager: Dr. Reddy's Laboratories Limited
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated May 2, 2019

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Ranitidine 75 mg (as ranitidine hydrochloride, USP 84 mg)

  • Purpose

    Acid reducer

  • Uses

    • relieves heartburn associated with acid indigestion and sour stomach
    • prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain foods and beverages
  • Warnings

    Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

    Do not use

    • if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools.
      These may be signs of a serious condition. See your doctor.
    • with other acid reducers

    Ask a doctor before use if you have

    • had heartburn over 3 months. This may be a sign of a more serious condition.
    • heartburn with lightheadedness, sweating or dizziness
    • chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness
    • frequent chest pain
    • frequent wheezing, particularly with heartburn
    • unexplained weight loss
    • nausea or vomiting
    • stomach pain
    • kidney disease

    Ask a doctor or pharmacist before use if you are

    • taking a prescription drug. Acid reducers may interact with certain prescription drugs.

    Stop use and ask a doctor if

    • your heartburn continues or worsens
    • you need to take this product for more than 14 days

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    • adults and children 12 years and over:
      • to relieve symptoms, swallow 1 tablet with a glass of water
      • to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
      • can be used up to twice daily (do not take more than 2 tablets in 24 hours)
      • do not chew tablet
    • children under 12 years: ask a doctor
  • Other information

    • this product is sodium and sugar free
    • Blister: do not use if individual blister unit is open or torn
      Bottle: do not use if printed foil under bottle cap is open or torn
    • avoid excessive heat or humidity
    • store at 20°-25°C (68°-77°F)
  • Inactive ingredients

    FD&C red #40 aluminum lake, hypromellose, iron oxide black, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide.

  • QUESTIONS

    Questions? call 1-888-375-3784

    Read the directions, consumer information leaflet and warnings before use. Keep the carton. It contains important information.

  • PRINCIPAL DISPLAY PANEL

    Ranitidine Tablets USP, 75 mg - container label

    container

  • PRINCIPAL DISPLAY PANEL

    Ranitidine Tablets USP, 75 mg - Container CartonLabel

    containercarton

  • INGREDIENTS AND APPEARANCE
    RANITIDINE 
    ranitidine tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55111-131
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    ranitidine hydrochloride (UNII: BK76465IHM) (ranitidine - UNII:884KT10YB7) ranitidine75 mg
    Inactive Ingredients
    Ingredient NameStrength
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    magnesium stearate (UNII: 70097M6I30)  
    cellulose, microcrystalline (UNII: OP1R32D61U)  
    Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A)  
    ferrosoferric oxide (UNII: XM0M87F357)  
    titanium dioxide (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorPINKScoreno score
    ShapeROUNDSize7mm
    FlavorImprint Code P75
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:55111-131-301 in 1 CARTON03/01/2000
    130 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:55111-131-601 in 1 CARTON03/01/2000
    260 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:55111-131-801 in 1 CARTON03/01/2000
    380 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:55111-131-901 in 1 CARTON03/01/2000
    490 in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:55111-131-041 in 1 CARTON03/01/2000
    5120 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:55111-131-371 in 1 CARTON03/01/2000
    6160 in 1 BOTTLE; Type 0: Not a Combination Product
    7NDC:55111-131-791 in 1 CARTON03/01/2000
    710 in 1 BLISTER PACK; Type 0: Not a Combination Product
    8NDC:55111-131-142 in 1 CARTON03/01/2000
    810 in 1 BLISTER PACK; Type 0: Not a Combination Product
    9NDC:55111-131-813 in 1 CARTON03/01/2000
    910 in 1 BLISTER PACK; Type 0: Not a Combination Product
    10NDC:55111-131-451 in 1 CARTON03/01/2000
    1045 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA07529403/01/2000
    Labeler - Dr. Reddy's Laboratories Limited (650562841)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!